The company based in Pennsylvania(PA)reported a risein revenue to $76.28 milion for the year when compared to $74.65 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 7,2023 showed that its revenue is up 2.18% year-over-year.
The company reported basic earnings per share of $null and diluted earnings per share of $null.
Optinose, Inc. operates in the Pharmaceutical Preparations sector.
Related News
